173 related articles for article (PubMed ID: 34965125)
1. Development of PDE6D and CK1α Degraders through Chemical Derivatization of FPFT-2216.
Teng M; Lu W; Donovan KA; Sun J; Krupnick NM; Nowak RP; Li YD; Sperling AS; Zhang T; Ebert BL; Fischer ES; Gray NS
J Med Chem; 2022 Jan; 65(1):747-756. PubMed ID: 34965125
[TBL] [Abstract][Full Text] [Related]
2. FPFT-2216, a Novel Anti-lymphoma Compound, Induces Simultaneous Degradation of IKZF1/3 and CK1α to Activate p53 and Inhibit NFκB Signaling.
Kanaoka D; Yamada M; Yokoyama H; Nishino S; Kunimura N; Satoyoshi H; Wakabayashi S; Urabe K; Ishii T; Nakanishi M
Cancer Res Commun; 2024 Feb; 4(2):312-327. PubMed ID: 38265263
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of lenalidomide-induced CK1α degradation by the CRL4(CRBN) ubiquitin ligase.
Petzold G; Fischer ES; Thomä NH
Nature; 2016 Apr; 532(7597):127-30. PubMed ID: 26909574
[TBL] [Abstract][Full Text] [Related]
4. CK1α and IRF4 are essential and independent effectors of immunomodulatory drugs in primary effusion lymphoma.
Patil A; Manzano M; Gottwein E
Blood; 2018 Aug; 132(6):577-586. PubMed ID: 29954751
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide screen identifies cullin-RING ligase machinery required for lenalidomide-dependent CRL4
Sievers QL; Gasser JA; Cowley GS; Fischer ES; Ebert BL
Blood; 2018 Sep; 132(12):1293-1303. PubMed ID: 30042095
[TBL] [Abstract][Full Text] [Related]
6. The Casein kinase 1α agonist pyrvinium attenuates Wnt-mediated CK1α degradation via interaction with the E3 ubiquitin ligase component Cereblon.
Shen C; Nayak A; Neitzel LR; Yang F; Li B; Williams CH; Hong CC; Ahmed Y; Lee E; Robbins DJ
J Biol Chem; 2022 Aug; 298(8):102227. PubMed ID: 35780831
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs.
Fuchs O
Cardiovasc Hematol Disord Drug Targets; 2019; 19(1):51-78. PubMed ID: 29788898
[TBL] [Abstract][Full Text] [Related]
8. Design and Development of IKZF2 and CK1α Dual Degraders.
Miyamoto DK; Curnutt NM; Park SM; Stavropoulos A; Kharas MG; Woo CM
J Med Chem; 2023 Dec; 66(24):16953-16979. PubMed ID: 38085607
[TBL] [Abstract][Full Text] [Related]
9. Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell lines.
Nishiguchi G; Mascibroda LG; Young SM; Caine EA; Abdelhamed S; Kooijman JJ; Miller DJ; Das S; McGowan K; Mayasundari A; Shi Z; Barajas JM; Hiltenbrand R; Aggarwal A; Chang Y; Mishra V; Narina S; Thomas M; Loughran AJ; Kalathur R; Yu K; Zhou S; Wang X; High AA; Peng J; Pruett-Miller SM; Daniels DL; Urh M; Shelat AA; Mullighan CG; Riching KM; Zaman GJR; Fischer M; Klco JM; Rankovic Z
Nat Commun; 2024 Jan; 15(1):482. PubMed ID: 38228616
[TBL] [Abstract][Full Text] [Related]
10. The E3 ubiquitin ligase component, Cereblon, is an evolutionarily conserved regulator of Wnt signaling.
Shen C; Nayak A; Neitzel LR; Adams AA; Silver-Isenstadt M; Sawyer LM; Benchabane H; Wang H; Bunnag N; Li B; Wynn DT; Yang F; Garcia-Contreras M; Williams CH; Dakshanamurthy S; Hong CC; Ayad NG; Capobianco AJ; Ahmed Y; Lee E; Robbins DJ
Nat Commun; 2021 Sep; 12(1):5263. PubMed ID: 34489457
[TBL] [Abstract][Full Text] [Related]
11. Discovery of CRBN-dependent WEE1 Molecular Glue Degraders from a Multicomponent Combinatorial Library.
Razumkov H; Jiang Z; Baek K; You I; Geng Q; Donovan KA; Tang MT; Metivier RJ; Mageed N; Seo P; Li Z; Byun WS; Hinshaw SM; Sarott RC; Fischer ES; Gray NS
bioRxiv; 2024 May; ():. PubMed ID: 38746375
[TBL] [Abstract][Full Text] [Related]
12. p97/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates.
Nguyen TV; Li J; Lu CJ; Mamrosh JL; Lu G; Cathers BE; Deshaies RJ
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3565-3571. PubMed ID: 28320958
[TBL] [Abstract][Full Text] [Related]
13. Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS Signaling.
Yelland T; Garcia E; Parry C; Kowalczyk D; Wojnowska M; Gohlke A; Zalar M; Cameron K; Goodwin G; Yu Q; Zhu PC; ElMaghloob Y; Pugliese A; Archibald L; Jamieson A; Chen YX; McArthur D; Bower J; Ismail S
J Med Chem; 2022 Feb; 65(3):1898-1914. PubMed ID: 35104933
[TBL] [Abstract][Full Text] [Related]
14. Caspase-8 Inhibition Prevents the Cleavage and Degradation of E3 Ligase Substrate Receptor Cereblon and Potentiates Its Biological Function.
Zhou L; Yu W; Jayabalan DS; Niesvizky R; Jaffrey SR; Huang X; Xu G
Front Cell Dev Biol; 2020; 8():605989. PubMed ID: 33392195
[TBL] [Abstract][Full Text] [Related]
15.
Fink EC; McConkey M; Adams DN; Haldar SD; Kennedy JA; Guirguis AA; Udeshi ND; Mani DR; Chen M; Liddicoat B; Svinkina T; Nguyen AT; Carr SA; Ebert BL
Blood; 2018 Oct; 132(14):1535-1544. PubMed ID: 30064974
[TBL] [Abstract][Full Text] [Related]
16. Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs.
Lindner S; Steinebach C; Kehm H; Mangold M; Gütschow M; Krönke J
J Vis Exp; 2019 May; (147):. PubMed ID: 31157769
[TBL] [Abstract][Full Text] [Related]
17. IMiDs induce FAM83F degradation via an interaction with CK1α to attenuate Wnt signalling.
Dunbar K; Macartney TJ; Sapkota GP
Life Sci Alliance; 2021 Feb; 4(2):. PubMed ID: 33361334
[TBL] [Abstract][Full Text] [Related]
18. USP15 antagonizes CRL4
Nguyen TV
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34583995
[TBL] [Abstract][Full Text] [Related]
19. Homo-PROTACs for the Chemical Knockdown of Cereblon.
Steinebach C; Lindner S; Udeshi ND; Mani DC; Kehm H; Köpff S; Carr SA; Gütschow M; Krönke J
ACS Chem Biol; 2018 Sep; 13(9):2771-2782. PubMed ID: 30118587
[TBL] [Abstract][Full Text] [Related]
20. An Improved PDE6D Inhibitor Combines with Sildenafil To Inhibit
Kaya P; Schaffner-Reckinger E; Manoharan GB; Vukic V; Kiriazis A; Ledda M; Burgos Renedo M; Pavic K; Gaigneaux A; Glaab E; Abankwa DK
J Med Chem; 2024 May; ():. PubMed ID: 38758695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]